Citation: Pr. Koduri et Sj. Naides, TRANSIENT BLOOD PLASMACYTOSIS IN PARVOVIRUS B19 INFECTION - A REPORT OF 2 CASES, Annals of hematology, 72(1), 1996, pp. 49-51
Citation: Sj. Naides et al., PARVOVIRUS B19 AS AN ETIOLOGIC AGENT OF FULMINANT NON-A, NON-B, NON-C, NON-E HEPATITIS (HNA-E) - EVIDENCE FOR PRODUCTIVE VIRAL-INFECTION, The FASEB journal, 10(6), 1996, pp. 26-26
Authors:
NAIDES SJ
KARETNYI YV
MARKIN S
LANGNAS AN
Citation: Sj. Naides et al., HUMAN PARVOVIRUS B19 HEPATOTROPIC GENETIC VARIANT(S) AS AGENT(S) OF NON-A, NON-B, NON-C, NON-E FULMINANT LIVER-FAILURE (NA-EFLF), Arthritis and rheumatism, 39(9), 1996, pp. 717-717
Authors:
CHERNAK E
DUBIN G
HENRY D
NAIDES SJ
HODINKA RL
MACGREGOR RR
FRIEDMAN HM
Citation: E. Chernak et al., INFECTION DUE TO PARVOVIRUS B19 IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 20(1), 1995, pp. 170-173
Authors:
LANGNAS AN
MARKIN RS
CATTRAL MS
NAIDES SJ
Citation: An. Langnas et al., PARVOVIRUS B19 AS A POSSIBLE CAUSATIVE AGENT OF FULMINANT LIVER-FAILURE AND ASSOCIATED APLASTIC-ANEMIA, Hepatology, 22(6), 1995, pp. 1661-1665
Authors:
LANGNAS AN
MARKIN RS
CATTRAL M
KARETNYI Y
COOLING LLW
KOERNER TAW
NAIDES SJ
Citation: An. Langnas et al., PARVOVIRUS B19 AS A POSSIBLE CAUSE OF ACUTE LIVER-FAILURE - CLINICAL AND MOLECULAR EVIDENCE, Hepatology, 22(4), 1995, pp. 1351-1351
Citation: Llw. Cooling et al., MULTIPLE GLYCOSPHINGOLIPIDS DETERMINE THE TISSUE TROPISM OF PARVOVIRUS B19, The Journal of infectious diseases, 172(5), 1995, pp. 1198-1205
Citation: Sj. Naides et al., PARVOVIRUS B19 AS A CAUSATIVE AGENT OF FULMINANT LIVER-FAILURE AND ASSOCIATED APLASTIC-ANEMIA, Arthritis and rheumatism, 38(9), 1995, pp. 273-273
Citation: Sj. Naides et al., MULTIPLE GLYCOSPHINGOLIPIDS DETERMINE THE TISSUE TROPISM OF PARVOVIRUS B19, Arthritis and rheumatism, 38(9), 1995, pp. 274-274
Citation: Sj. Naides, ACUTE PARVOVIRUS B19-INDUCED PANCYTOPENIA IN THE SETTING OF METHOTREXATE THERAPY FOR RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 38(7), 1995, pp. 1023-1023
Authors:
LANGNAS AN
MARKIN RS
TRUE CA
CATTRAL MS
NAIDES SJ
Citation: An. Langnas et al., PARVOVIRUS-B19 AS A CAUSATIVE AGENT OF FULMINANT LIVER-FAILURE AND ASSOCIATED APLASTIC-ANEMIA, Hepatology, 20(4), 1994, pp. 10000310-10000310
Authors:
NAIDES SJ
HOWARD EJ
SWACK NS
TRUE CA
STAPLETON JT
Citation: Sj. Naides et al., CEFTRIAXONE FOR PEDIATRIC-PATIENTS WITH LYME-DISEASE - REPLY, The Journal of infectious diseases, 169(4), 1994, pp. 939-940
Authors:
LANGNAS AN
MARKIN RS
TRUE CA
CATTRAL MS
NAIDES SJ
Citation: An. Langnas et al., PARVOVIRUS B19 AS A CAUSATIVE AGENT OF FULMINANT LIVER-FAILURE AND ASSOCIATED APLASTIC-ANEMIA, Clinical research, 42(3), 1994, pp. 10000407-10000407
Authors:
NAIDES SJ
HOWARD EJ
SWACK NS
TRUE CA
STAPLETON JT
Citation: Sj. Naides et al., PARVOVIRUS B19 INFECTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PERSONS FAILING OR INTOLERANT TO ZIDOVUDINE THERAPY, The Journal of infectious diseases, 168(1), 1993, pp. 101-105
Citation: Kg. Saag et al., INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF CHRONIC PARVOVIRUS-B19 ARTHROPATHY, Arthritis and rheumatism, 36(9), 1993, pp. 190000067-190000067